News | Radiation Oncology | September 21, 2026

Radformation has received FDA 510(k) clearance for its OptiPlan Automated VMAT Planning.

Automated VMAT Planning Receives FDA Clearance

Sept.21, 2026 — Radformation, a provider of intelligent automation solutions for radiation oncology, has expanded U.S. Food and Drug Administration (FDA) 510(k) clearance (K261718) for EZFluence to include OptiPlan*, its automated VMAT planning module. The clearance makes OptiPlan available for clinical use in the United States, expanding access following its introduction in Europe and Canada. 

“OptiPlan was built in direct response to what we were hearing from our users. Treatment planners need ways to work more efficiently without giving up control over clinical decisions,” said Jayne Churness, Director of Product Management at Radformation. “By automating repetitive optimization work while keeping clinicians at the center of the process, OptiPlan gives planners more time to focus on the decisions where their expertise matters most.” 

OptiPlan leverages patient anatomy and clinical priorities defined through ClearCheck templates to generate high-quality VMAT plans without model training or commissioning. Planners can refine the balance between target coverage and organ-at-risk sparing by comparing plan options side by side before selecting the approach that best meets the patient’s clinical objectives.

More information about OptiPlan can be found at radformation.com/optiplan/optiplan.

 

*OptiPlan automated VMAT planning is an optional module of EZFluence and is not available in all markets. Availability is subject to applicable regulatory approvals.

 

Radformatiom FDA

 


Additional Content

News | Lung Imaging

Nov.2, 2026 – SimonMed has announced the clinical launch of two advanced lung imaging technologies, CT:VQ and LDAf, in ...

Time November 02, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | ASTRO

Oct. 5, 2026 — The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2026 Gold Medal ...

Time October 07, 2026
arrow
News | Pediatric Imaging

Sept. 29, 2026 — Visiana has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Time October 02, 2026
arrow
News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
Subscribe Now